These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3724070)

  • 1. A thin layer chromatographic method for high volume screening of urine for methylphenidate abuse.
    Manno BR; Manno JE; Dempsey CA
    J Anal Toxicol; 1986; 10(3):116-9. PubMed ID: 3724070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of ritalinic acid in urine by thin-layer chromatography and gas chromatography.
    Allen HW; Sedgwick B
    J Anal Toxicol; 1984; 8(2):61-2. PubMed ID: 6716975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography-tandem mass spectrometry, gas chromatography-mass spectrometry, and immunoassay methods.
    Eichhorst J; Etter M; Lepage J; Lehotay DC
    Clin Biochem; 2004 Mar; 37(3):175-83. PubMed ID: 14972638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A routine screening method for the major metabolite of methyl phenidate in the urine of greyhounds.
    Lewis JH
    Forensic Sci Int; 1979 Nov; 14(3):221-7. PubMed ID: 511053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reproducible gas chromatographic mass spectrometric assay for low levels of methylphenidate and ritalinic acid in blood and urine.
    Milberg RM; Rinehart KL; Sprague RL; Sleator EK
    Biomed Mass Spectrom; 1975 Feb; 2(1):2-8. PubMed ID: 1131389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous detection of methylphenidate and its main metabolite, ritalinic acid, in doping control.
    Solans A; Carnicero M; De La Torre R; Segura J
    J Chromatogr B Biomed Appl; 1994 Aug; 658(2):380-4. PubMed ID: 7820267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous detection of a wide variety of commonly abused drugs in a urine screening program using thin-layer identification techniques.
    Kaistha KK; Tadrus R; Janda R
    J Chromatogr; 1975 Apr; 107(2):359-79. PubMed ID: 1137995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A safer methylation procedure with boron trifluoride-methanol reagent for gas chromatographic analysis of ritalinic acid in urine.
    Vu-Duc T; Vernay A
    J Pharm Biomed Anal; 1992; 10(2-3):187-91. PubMed ID: 1391098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of amphetamine and methylphenidate in exhaled breath of patients undergoing attention-deficit/hyperactivity disorder treatment.
    Beck O; Stephanson N; Sandqvist S; Franck J
    Ther Drug Monit; 2014 Aug; 36(4):528-34. PubMed ID: 24452069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of methylphenidate and its metabolite ritalinic acid in urine by liquid chromatography/tandem mass spectrometry.
    Paterson SM; Moore GA; Florkowski CM; George PM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 881-882():20-6. PubMed ID: 22204874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the measurement of drugs of abuse by commercial and in-house horizontal thin layer chromatography.
    Wolff K; Sanderson MJ; Hay AW; Barnes I
    Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():163-8. PubMed ID: 8466147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening of benzo- and thienodiazepines in urine with Emit ST and thin-layer chromatography within the scope of substance abuse].
    Gruhl H
    Z Rechtsmed; 1987; 98(4):221-8. PubMed ID: 2889301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of costs for testing a wide variety of drugs of abuse per urine specimen in a drug abuse urine screening program and frequent urine collections.
    Kaistha KK; Tadrus R
    J Chromatogr; 1975 Jun; 109(1):149-62. PubMed ID: 1138000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of an internal standard in a single-solvent thin-layer chromatographic analysis for drugs of abuse in urine.
    Bress WC
    Clin Chem; 1979 Aug; 25(8):1515-6. PubMed ID: 455704
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxicological analysis of weckamines (amphetamine, pervitin, preludin and ritalin) in pharmacuetical compounds and urine of persons suspected from doping.
    Heyndrickx A; De Leenheer A
    J Pharm Belg; 1967; 22(3):109-26. PubMed ID: 5611582
    [No Abstract]   [Full Text] [Related]  

  • 16. Thin-layer chromatographic screening and confirmation of basic drugs of abuse in urine.
    Jain NC; Leung WJ; Budd RD; Sneath TC
    J Chromatogr; 1975 Dec; 115(2):519-26. PubMed ID: 1206062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thin-layer detection of diazepam and/or chilordiazepoxide alone or in combination with major drugs of abuse in drug abuse urine screening programs.
    Kaistha KK; Tadrus R
    J Chromatogr; 1978 Jul; 154(2):211-8. PubMed ID: 681472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gas-liquid chromatographic procedure for measurement of methylphenidate hydrochloride and its metabolite, ritalinic acid, in urine.
    Wells R; Hammond KB; Rodgerson DO
    Clin Chem; 1974 Apr; 20(4):440-3. PubMed ID: 4818196
    [No Abstract]   [Full Text] [Related]  

  • 19. A rapid method for screening urine samples in suspected abuse of cocaine.
    Hsu LS; Sharrard JI; Love C; Marrs TC
    Ann Clin Biochem; 1981 Nov; 18(Pt 6):368-72. PubMed ID: 7316455
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alcohol and drugs in blood and urine. 100 consecutive cases of persons arrested by the Stockholm police].
    Allgén LG; Bergsman A; Sandberg A; Bejerot N; Hellström L
    Lakartidningen; 1971 Jun; 68(30):3405-14. PubMed ID: 5096171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.